Anesthesiology · White Plains, NY
NPI
1376886929
Since 2013
Specialty
Anesthesiology
Code 207L00000X
Group practices
8
Medicare group memberships
Hospitals
3
Hospital affiliations
41 E Post Rd
White Plains, NY, 10601
Phone (914) 681-0600
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
334 services
Medicare patients, 2024
202
Average age 73
Drug cost, 2024
$109K
1,547 prescriptions
Company payments, 2025
$2,251
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luis F Chabla-Penafiel was code 01638 (anesthesia), 50 times for 50 patients. In total Luis F Chabla-Penafiel billed 334 services in 60 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 01638 Anesthesia | Facility | 50 | 50 | $198.24 | $9,912 |
| 76942 Ultrasound - Nonspecific | Facility | 48 | 47 | $27.61 | $1,325 |
| 99213 Office E&M - Established | Office | 31 | 20 | $81.59 | $2,529 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 21 | $73.64 | $1,694 |
| 01630 Anesthesia | Facility | 22 | 22 | $140.17 | $3,084 |
| 36620 Vascular | Facility | 11 | 11 | $41.08 | $452 |
| 99203 Office E&M - New | Office | 11 | 11 | $107.31 | $1,180 |
| 01214 Anesthesia | Facility | 11 | 11 | $180.86 | $1,989 |
By year: 2022 $51K for 383 services; 2023 $36K for 292 services; 2024 $38K for 334 services.
Medicare prescription drug claims, 2024
In 2024, the drug Luis F Chabla-Penafiel prescribed most often to Medicare patients was Doxepin Hcl, with 485 prescriptions and refills. In total Luis F Chabla-Penafiel wrote 1,547 Medicare prescriptions that cost $109K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxepin Hcl Generic | 485 | 485 | 26 | $49K |
| Diclofenac Sodium Er Diclofenac Sodium | 482 | 482 | 27 | $37K |
| Gabapentin Generic | 147 | 302 | 54 | $1,975 |
| Pregabalin Generic | 90 | 103 | 24 | $4,075 |
| Duloxetine Hcl Generic | 41 | 82 | 11 | $870 |
| Tizanidine Hcl Generic | 40 | 87 | 25 | $348 |
| Lidocaine Generic | 25 | 25 | Under 11 | $2,926 |
| Etodolac Generic | 23 | 29 | 20 | $3,208 |
| Diclofenac Sodium Generic | 21 | 23 | Under 11 | $272 |
| Meloxicam Generic | 20 | 28 | 15 | $52.17 |
| Tramadol Hcl Generic | 19 | 19 | Under 11 | $36.11 |
| Baclofen Generic | 17 | 36 | 11 | $349 |
| Naproxen Sodium Generic | 16 | 16 | 16 | $1,239 |
| Methocarbamol Generic | 16 | 24 | Under 11 | $362 |
| Topiramate Generic | 12 | 16 | Under 11 | $166 |
Brand drugs: 17 claims; generic drugs: 1,530 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luis F Chabla-Penafiel $2,251 ($2,251 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $2,251.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 27 | $2,251 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.